Skip to content

EPID and Octavius 4D in Volume Modulated Arc Therapy Study on Dose Verification

EPID and Octavius 4D in Volume Modulated Arc Therapy Study on Dose Verification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092370
Enrollment
Unknown
Registered
2024-11-14
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal cancer

Interventions

Observational group:None

Sponsors

the Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosed as head metastasis, mid thoracic esophageal cancer, and pelvic cervical cancer through clinical examination;

Exclusion criteria

Exclusion criteria: 1.Patients with mental illness;

Design outcomes

Primary

MeasureTime frame
Dose error sensitivity;

Countries

China

Contacts

Public ContactTiezhu Mao

the Second Hospital of Jilin University

maotz@jlu.edu.cn+86 13044305027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026